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Abstract 
Since its discovery in 1974, SERS has gained momentum as an important tool in analytical 
chemistry. SERS has been used widely for analysis of biological samples ranging from in vitro 
cell culture models, to ex vivo tissue and blood samples, to direct in vivo application. New 
insights into biochemistry with an emphasis on biomolecule detection, from small molecules 
such as glucose and amino acids, to larger biomolecules such as DNA, proteins and lipids, has 
been gained. These measurements have increased our understanding of biological systems 
and, significantly, increased diagnostic capabilities. SERS probes have displayed unique 
advantages in their detection sensitivity and multiplexing capability. We will highlight key 
considerations required when performing bioanalytical SERS measurements, including 
sample preparation, probe selection, instrumental configuration, and data analysis. Some of 
the key bioanalytical measurements enabled by SERS probes with application to in vitro, ex 
vivo, and in vivo biological environments will be discussed. 
 
1. Introduction 
1.1 SERS and its application to biological analysis 
Raman scattering is an inelastic process that exploits the fact that individual bonds give rise 
to unique vibrations, resulting in molecularly specific spectra.(1) Due to the fingerprint nature 
of Raman spectra, this allows individual components within a sample mixture to be identified. 
However, Raman scattering is an inherently weak process, with only approximately 1 in 106 
photons being inelastically scattered. Research carried out by Fleischmann et al.(2) in the 
1970s, and developed by Jeanmaire and Van Duyne(3), led to the discovery that by adsorbing 
the molecule of interest onto a roughened metal surface, the Raman signal could be 
significantly enhanced(4), establishing the method that is now known as surface enhanced 
Raman scattering (SERS). Enhancement factors of 104-108 compared to conventional Raman 
have been reported.(5-7) The most common materials used to provide the roughened metal 
surface for SERS are colloidal suspensions of gold and silver nanoparticles due to their surface 
plasmons existing in the visible region of the electromagnetic spectrum. This is extremely 
beneficial when using laser excitations of 633 and 785 nm, commonly used for Raman 
analysis.  
 
SERS has been widely applied for detection of biological molecules and systems such as 
proteins(8), DNA(9, 10) and cells.(11) One of the many advantages of using Raman for the 
analysis of biological samples is the amount of information that is obtained about molecular 
properties. The recent developments in chemometrics and multivariate analysis have made 
it even more accessible for Raman to be used to analyse complex biological samples.(12) 
 
1.2 Key considerations when making bioanalytical SERS measurements  
SERS is an important tool for the analysis of biological samples and this section will highlight 
the key considerations required when performing bioanalytical measurements with said 
probes before highlighting some of the seminal advances in the use of SERS probes in in vitro, 
ex vivo, and in vivo environments. In order to perform optimal measurements for particular 
application, careful consideration must be made with respect to the selection of preparation 
methods for the biological samples to be analyzed, appropriate SERS probes, a suitable 
instrument configuration, and appropriate data processing and analysis methods. These 
considerations are summarized in Figure 1. 
 
1.2.1 Biological sample preparation 
Consideration must be given to how a biological sample will be prepared for SERS 
measurement. In the case of in vitro samples, cells can be fixed or live. Often measurements 
will only be physiologically relevant if obtained using live cells for example using SERS probes 
for pH sensing.(13) Fixed cells are far easier to work with, specifically when SERS probes are 
utilized, as cell toxicity may be mitigated. However, fixing cells chemically modifies the cells 
and could introduce artifacts as a consequence of the fixing process.  For ex vivo blood 
samples, the blood can be analyzed as whole blood, or by collecting the red blood cell, plasma 
or serum components.(14, 15) Ex vivo tissue samples tend to be processed by fixation (either 
chemical or freezing) followed by sectioning. Chemical fixation is the most common and tends 
to be followed by paraffin embedding and sectioning, including a number of dehydration and 
rehydration steps. Again, these steps can introduce artifacts that may interfere with SERS 
measurements. Excised tissue can be analyzed directly but this is less common. In vivo 
measurements ultimately require the patient to be alive, and therefore, there are no sample 
preparation steps; rather, the SERS probes have to be designed to integrate into this living 
environment. In all cases, consideration must be taken of other biomolecules that might 
interfere with SERS measurements, such as bovine serum albumin (BSA) in cell culture media 
and additional blood proteins in blood samples.(16) Background fluorescence, particularly for 
in vivo samples, can also create measurement interference. However, careful choice of laser 
wavelength can diminish these effects, as will be discussed in section 1.2.3. 
 
 
 
1.2.2 SERS probe selection 
When selecting the ideal SERS probe for a particular bioanalytical measurement, 
consideration must be made to a number of factors. Schlücker(17) concisely summarized the 
required components of a SERS probe as a metal nanoparticle, SERS substrate, functionalized 
with a Raman reporter label and a biomolecule. (Figure 2) In some cases, none of these 
components are added where direct SERS measurement are recorded from biomolecules that 
are in close proximity to unfunctionalized metal nanoparticles.(18) However, each of these 
components will be briefly discussed along with their application-dependent presence or 
absence, and potential variations of each. 
 
Typically, gold and silver are the metals of choice as SERS substrates due to their optimal 
optical properties as they have plasmon resonances that lie in the visible and near-infrared 
(NIR) range. The plasmon resonance of nanoparticles can be tuned by careful selection of 
nanoparticle size, and in the case of nanoshells, core-to-shell ratio.(19) Optimal laser 
wavelength for particular application can be used by selecting a nanoparticle with the desired 
plasmon resonance.   
 
Gold(20) and functionalized silver(21) nanoparticles also exhibit low toxicity with application 
to biological systems. In particular, gold nanoparticles are inert, and have been approved for 
use in live humans for particular applications already.(22) For this reason, in vitro and in vivo 
applications will often use gold nanoparticles as the substrate of choice. Silver, however, 
tends to exhibit superior scattering properties and larger enhancement of Raman signals.(23) 
Therefore, in ex vivo application where nanoparticles are not being applied directly to living 
systems, silver may be preferable. While bare silver nanoparticles have displayed cytotoxic 
effects, and gold is therefore favored for in vitro and in vivo work, studies have shown that 
this toxicity can be mitigated after functionalization. The mechanism behind silver 
nanoparticle toxicity and its reduction after functionalization are not fully understood but 
have been attributed to characteristics including surface area, size, shape, charge and the use 
of different capping agents, which can reduce interference of the nanoparticle with the 
surrounding biological environment.(24) 
 
Most often, measurements are made indirectly via a Raman reporter label, often a dye 
molecule added to the surface of the nanoparticles. In this case the signal from the dye 
molecule is measured as an indication of, for example, a binding event between the 
nanoparticle and desired target molecule. In the case of surface enhanced resonance Raman 
spectroscopy (SERRS) signals are further enhanced, and sensitivity increased, by selecting a 
dye that absorbs at a wavelength close to the laser excitation wavelength.(25) Raman labels 
and biomolecules can be attached electrostatically or covalently to the chosen SERS substrate 
(Figure 2).(19) Additionally, protective coatings, such as poly-ethylene glycol (PEG) and silica, 
are often applied to nanoparticles for multiple purposes including to avoid dissociation of 
functionalized molecules, reduce toxicity and aid further functionalization, as discussed 
extensively by Wang et al.(19). Finally, in order to target a specific molecule, biorecognition 
molecules can be functionalized onto the surface of the nanoparticles. These include 
oligonucleotides and antibodies to target specific DNA/RNA sequences and proteins 
respectively.(26) Both dyes and biomolecules have been attached to nanoparticles using a 
number of different approaches which include  electrostatic attraction between the 
nanoparticle surface and dye/biomolecule(25), or covalent attachment, via, for example, 
EDC/NHS coupling(27). Where both a dye and a biomolecule have been used, these can both 
be attached directly to the nanoparticle surface(28), or can be attached directly as one species 
where the biomolecule has the dye pre-attached(29) (Figure 2).   
 
1.2.3 Instrumental considerations 
Raman instrumentation is another important consideration when utilizing SERS probes for 
ďŝŽĂŶĂůǇƐŝƐ ?dŚĞ “ŝĚĞĂůŝŶƐƚƌƵŵĞŶƚ ?ĨŽƌĂŐŝǀĞŶĂƐƐĂǇĐĂŶǀĂƌǇƐŝŐŶŝĨŝĐĂŶtly based on the SERS 
probes, the sample format and the amount and type of information that is required. Once a 
probe is selected, the first decision to make is often laser wavelength. One of the many 
benefits of Raman spectroscopy is the ability to use one or many laser excitation wavelengths 
to perform a measurement. However, the use of SERS probes may complicate this choice, as 
the laser excitation wavelength that will result in optimal performance may vary based on the 
core particle plasmon resonance and resonant contributions from Raman reporter dyes. 
Further complicating this matter is the presence of auto-fluorescence from biological 
components and poor tissue penetration depth of visible excitation wavelengths. Accordingly, 
many SERS measurements are now being performed with near-IR (NIR) wavelength 
excitation(30-32), which may help to mitigate fluorescence and increase tissue penetration in 
future applications. 
 
In terms of measurement format, point and shoot Raman spectroscopy can be applied 
broadly to in vitro, ex vivo, and in vivo measurements. Traditional, backscattering Raman 
spectroscopy is common in measurements aimed at understanding spectral variations as a 
result of biological processes, quantificatiŽŶ ?ĂŶĚŵĞĂƐƵƌŝŶŐ “ŽŶ ?ŽĨĨ ?ƐŝŐŶĂůǀĂƌŝĂƚŝŽŶƐ ? 
 
Applications where one seeks to gain spatial information about biomarker or tag distribution 
or location, common in in vitro and ex vivo studies, often rely on Raman microscopy, with 
confocal mapping in two or three dimensions.(33) Recent advances have also demonstrated 
mapping in vivo.(34) Further, a given measurement may call for a dedicated piece of 
equipment. Specialized instruments include handheld or endoscopic probes,(35-38) small 
animal(39) and widefield imaging devices,(40) and instruments for spatially offset Raman 
spectroscopy (SORS),(41) capable of detecting SERS probes from depth in tissue(42, 43) and 
bone.(44) Some applications of these instruments will be discussed further in the following 
sections.  
 
1.2.4 Interpreting the data 
As with all analytical chemistry techniques, consideration must be taken into how the 
resulting data will be analysed. Similar to fluorescence, SERS probes can be used to give an 
 “ŽŶ ? ? ?ŽĨĨ ? ƚǇƉĞƌĞƐƉŽŶƐĞ ƚŽĂďŝŶĚŝŶŐ ŝŶƚĞƌĂĐƚŝŽŶ ?dŚŝƐ ĐĂŶďĞƋƵĂŶƚŝƚĂƚŝǀĞ ŝĨ ƚŚĞ ŝŶƚĞŶƐŝƚǇ
response of a signal is calibrated against known or independently measured values. This is an 
example of univariate analysis. Often more sophisticated chemometric methods are 
employed when analysing SERS data, involving multivariate analysis. Where SERS probes are 
used for direct measurement of biochemical signals from native molecules, the resulting 
spectra will contain information about a number of biological species that were in close 
proximity to the nanoparticle surface. In this case, principle component analysis (PCA) is often 
employed to reduce the dimensionality of the data by creating principle components that 
explain the maximum data set variation.(45) Another technique, partial least squares 
regression (PLSR) analysis, is a supervised multivariate analysis technique, where spectral 
response to known incremental experimental changes are modeled.(46) This has been used 
to improve multiplex SERS probe capability, by allowing individual probe contributions to 
multiplex spectra to be better distinguished and quantified.(47) Direct classical least squares 
(DCLS) analysis is a type of multivariate analysis technique that is also commonly employed 
to distinguish contributions from different SERS probes in a multiplex assay.(48, 49) The 
nature of SERS spectra, with multiple sharp distinguishing peaks, providing multivariate data, 
allows increased multiplexing capability in comparison to univariate fluorescence analysis.  
 
2. In vitro measurements 
There is a significant need for the development of non-invasive and non-destructive methods 
of disease detection and subsequent treatment. The main reasons driving the detection of 
biological targets in vitro using SERS are the ability to do so rapidly, sensitively whilst detecting 
multiple targets simultaneously. A strong motivation for performing in vitro studies is to lay 
the foundations for potential success of future in vivo studies although it should be noted that 
not all in vitro studies are designed to move in vivo.  
 
2.1 Label free nanoparticles for cellular analysis 
Metallic nanoparticles have been utilized extensively as sensors for cellular studies involving 
SERS. By combining the plasmonic properties offered by gold nanoparticles and the sensitivity 
of the SERS method, information on the cellular composition and its physical properties can 
be readily obtained.(18, 50, 51) In 2006, Kneipp et al.(52) used unfunctionalized gold 
nanoparticles as SERS sensors to measure the variances in endocytotic uptake in two different 
cell lines, mouse macrophage cells (J774) and immortalized rat renal proximal tubule cells 
(IRPT). The conclusion was that the rate of nanoparticle uptake through endocytosis can vary 
notably depending on the cell line used.  
 Other physiological processes, such as apoptosis, have been successfully monitored in a label 
free manner as demonstrated by Zhou et al.(53). The concept of their method was based on 
the deposition of silver nanoparticles directly onto the cell membrane. When apoptosis was 
induced by drug application, changes in the intrinsic Raman signal were readily monitored, 
with a view to transferring this method to allow the monitoring of other physiological 
processes. Measuring cellular drug response in this manner could also prove to be a vital tool 
for high throughput drug screening detection methods.(54) 
 
2.2 Labeled nanoparticles for cellular analysis 
There is no doubt that there are great rewards to be reaped by using gold nanoparticles as 
sensors for SERS analysis of cells. However, it has been shown that by functionalizing these 
gold nanoparticles with specific molecules, even more information on the cellular 
environment can be obtained. Nanoparticles functionalized with specific biomolecules can be 
designed to target specific cellular components, such as antibody functionalized nanoparticles 
for detection of specific antigens, resulting in high resolution spatial resolution imaging of 
specific cellular biomolecules. Lee et al.(55), using gold or silver nanoparticles functionalized 
with specific monoclonal antibodies and Raman reporter dye to produce highly sensitive 
Raman images of live HEK293 cells expressing a specific biomarker, ƉŚŽƐƉŚŽůŝƉĂƐĞ ɶ ?
(W>ɶ ?), known to be overexpressed in hyperproliferative human tissue, including many 
cancers. Antibody tagged SERS probes have been widely applied to in vitro cell culture studies, 
with application to cancer diagnostics, where a biomarker specific to or upregulated in 
cancerous cells is often imaged using antibody conjugated nanoparticles. Park et al.(56) used 
gold nanorods functionalized with the Raman dye reporter mercaptopyridine and secondary 
antibodies (anti-rabbit IgGs) to detect the presence of HER2 biomarker (upregulated in breast 
cancer) in MCF7 breast cancer cells targeted with HER2 specific antibodies. In 2013, Lee et 
al.(57) reported a SERS based method, using silica encapsulated hollow gold nanospheres, 
functionalized with specific Raman reporter dyes and antibodies to target breast cancer 
biomarkers epidermal growth factor (EGF), ErbB2 and insulin-like growth factor-1 (IGF-1). 
They applied these SERS probes for detection of biomarkers in MDA-MB-468, KPL4 and SK-
BR-3 human breast cancer cell lines, allowing breast cancer phenotyping. Not only do these 
studies provide a readily available platform for development of detection assays, which can 
ultimately be performed for direct in vivo early cancer detection, but they also provide 
important information in their own right, increasing insight into the biochemical processed 
behind cancer progression. These platforms could also be used in drug screening studies, 
where drug candidates could be tested for their effect on cancer biomarker expression. In 
2013, Stevenson et al.(58) demonstrated a new and important detection capability of a SERS 
probe in an in vitro environment where they were able to detect intracellular enzyme activity. 
ĐƚŝǀŝƚǇŽĨŝŶƚƌĂĐĞůůƵůĂƌɴ-galactosidase enzymes was measured by conversion of applied 5-
bromo-4-chloro-3-indoyl-ɴ-D-galactopyranoside (X-'Ăů ?ƚŽ ? ? ? ?ĚŝďƌŽŵŽ- ? ? ? ?-dichloro-indigo, 
detected by SERS via intracellularly applied gold nanoparticles. This study further highlights 
the vast capabilities of SERS for in vitro analysis.  
 
In addition to detecting specific biomolecules or enzyme activity, unique SERS probes have 
been developed to measure specific physiological characteristics of cells, particularly pH and 
redox potential. Early work by Bishnoi et al.(59) demonstrated the successful application of 
SERS for monitoring intracellular pH changes in the cell using a pH sensitive nanosensor 
consisting of a gold nanoshell with a self-assembled monolayer of the pH responsive 
molecule, para-mercaptobenzoic acid (pMBA). By monitoring the change in the protonation 
state of the pMBA via the SERS spectrum, information on pH changes within the cellular 
environment were readily obtained. This was quickly followed by Kneipp et al.(60), who 
further developed the concept of using pMBA as a pH indicator. A two photon excitation 
method, surface-enhanced hyper-Raman scattering (SEHRS), was used, allowing a wider pH 
range to be probed. These studies have paved the way to the work by the Campbell group in 
recent years.  In this work, particular attention was given to investigating cellular redox 
potential, due to its involvement in the regulation of a number of biochemical processes.(61) 
A library of SERS redox probes was developed by the group based on functionalizing 
nanoparticles with small redox active molecules, which report in a ratiometric manner on 
intracellular redox potential. These probes have been used to measure intracellular redox 
potential in NIH-3T3 fibroblast cells(62), A549 lung cancer cells before and after hypoxia 
induction(63) and PC3 prostate cancer cells before and after oxidative stress(64). Significantly, 
for the first time, simultaneous measurement of intracellular pH and redox potential using 
these SERS nanosensor probes was reported by Jamieson et al.(13) in 2015.  Camus et al.(65) 
and Jamieson et al.(66) have even recently applied these measurements to a three 
dimensional (3D) in vitro cell culture model, a significant advancement enabled by SERS 
probes, as current methods for analysing 3D culture models are incredibly limited. 3D in vitro 
culture models are becoming increasingly significant by providing a more realistic in vivo 
environment without the ethical considerations required for the use of in vivo or ex vivo 
samples.  
 
In vitro cellular pH sensing has also been achieved with sensing molecules other than pMBA. 
Lawson et al.(67) used the multifunctional molecule, 3, 5-dimercaptobenzoic acid that had 
the ability to cross link nanoparticles to form controlled aggregates, enhancing the observed 
Raman signal, but also acting as a pH sensor, similar to benzoic acid pMBA. The cells used in 
this particular work were human induced pluripotent stem cells (hiPSCs) and with the above 
substrate, the pH could be monitored across the entire physiological range. Further to this, 
Nie et al.(68) designed a multifunctional SERS substrate that allowed for pH sensing and drug 
delivery. The substrate consisted of a gold nanoparticle, conjugated to doxorubicin and 
polyethylene glycol, Au-dox-PEG. Doxorubicin was modified with a hydrozone linker that 
allowed for pH sensing, and ultimately the release of the molecule from the surface, which 
acted as a therapeutic drug for tumors. Additional to the therapeutic effect of doxorubicin, 
the molecule gave rise to a distinctive Raman spectrum, therefore allowing the drug release 
to be monitored by SERS. The results demonstrated successful drug release at acidic pH, all 
monitored by SERS. This work further provided the confidence in using SERS to detect and 
track specific drug delivery in tumor cells.  
 
A recent paper published by Chen et al.(69) provided an insight into the potential of SERS as 
a method for analyzing complex physiological processes within a cell, but did not focus on the 
use of pH sensing molecules. The study involved both label free and labeled SERS substrates, 
used for nuclear and membrane targeting in HeLa cells. The label free substrates were able 
to target specific regions of the cell due to the presence of specific targeting molecules, 
whereas the labeled substrates contained the targeting molecules along with Raman 
reporters: crystal violet (CV), cresyl violet acetate (CVa) and mercaptobenzoic acid (MBA), to 
be specific. From Figure 3, the gold nanoparticles are shown to have localized in the desired 
regions of the cell, and due to the enhanced optical field surrounding gold nanoparticles, the 
different Raman signatures of the different cellular components (fatty acids, proteins, DNA) 
could be readily observed. The second part of the figure shows the Raman image obtained 
when using the labeled gold nanoparticles for targeting the cell nucleus and cell membrane 
in the same cell. From the images, the position of the cell membrane and nucleus could be 
clearly defined due to the different reporters being used: CV (green) and CVa (red) represent 
the cell membrane and MBA (blue) represents the cell nucleus. The yellow color in the images 
represents an overlapping are of the two components. This study begins to reveal the 
multiplexing capabilities of SERS probes, allowing multiple characteristics to be probed 
simultaneously. In 2013, McAughtrie et al.(48) combined SERS probes and Raman imaging, to 
image the intracellular location of three different dye labelled silver nanoparticles. Not only 
did this study emphasize the multiplexing capabilities of SERS probes, which could ultimately 
by designed to target and image different cellular biomolecules, but cell imaging was carried 
out in 3D. Therefore, 3D location of the nanoparticles in the cell was obtained, a significant 
advancement in the field of SERS probes for in vitro analyses.  
 
SERS probes for in vitro bioanalysis have been widely exploited as demonstrated in this 
section. Much of this work paves the way for ex vivo and in vivo analysis, using a readily 
available biological model, which does not suffer from the same ethical restrictions as ex vivo 
and in vivo samples.  
 
 
3. Ex vivo measurements 
A large proportion of current diagnostic tests rely on accurate detection of disease biomarkers 
in ex vivo biological samples. Blood samples are routinely analyzed using common 
bioanalytical techniques including immunoassays (IA), enzyme-linked immunoassays (ELISA), 
western blots, fluorescence in situ hybridization (FISH), and polymerase chain reaction 
(PCR).(70) In addition to biofluid tests for diagnostic purposes, immunohistochemistry is a 
widely used technique for diagnosing tissue samples from a patient biopsy.(71) These well-
established bioanalytical techniques have been used as common practice for a number of 
years, however, the potential of SERS to be exploited in order to improve sensitivity of these 
ĐƵƌƌĞŶƚ ‘ŐŽůĚƐƚĂŶĚĂƌĚ ?ƚĞĐŚŶŝƋƵĞƐŝƐďĞĐŽŵŝŶŐĂŶ increasingly prominent area of research. 
SERS probes have been exploited for detection of small molecules such as glucose(72), as well 
as larger biomolecules, in particular proteins(73) and DNA(25) as disease markers, in biofluid 
samples. In addition, relatively recent work has demonstrated the scope for SERS probes to 
be used for ex vivo tissue analysis for the detection of disease markers in both tissue 
sections(74) and excised tissue samples(75). In addition to the potential for increased 
detection sensitivity using carefully designed SERS probes, a major advantage of SERS probes 
is their multiplexing capability, which will be discussed in reference to biofluid and tissue 
samples in the following sections.  
 
3.1 Ex vivo biofluids 
Blood is regularly extracted intravenously from patients to undergo a variety of analytical 
measurements. Whole blood, isolated red blood cells, and serum are commonly analyzed. 
There is a constant need to develop techniques that allow detection of biomolecules currently 
eluding detection and to achieve greater detection sensitivity in established assays. SERS-
based detection assays have emerged as promising tools for biomolecule detection in patient 
blood samples with sensitivities that compete with current gold standard methods. While 
there are examples of SERS assays based on direct measurement of native biomolecules in a 
sample, most assays use indirect mechanisms that detect signals from dye labeled 
nanoparticles targeted for detection of specific biomolecules, particularly oligonucleotide 
sequences and proteins.(26)  
 
The majority of SERS probes are based on indirect detection mechanisms, detecting SERS 
signals from Raman reporter dyes attached to the nanoparticles. For examples of direct SERS 
probe measurements, where native biomolecule signals are enhanced and detected, 
reference is made to Bantz et al.(76). In this review, the application of SERS probes for the 
detection of small biomolecules including glutathione, nicotinic acid adenine dinucleotide 
phosphate (NADDP), glucose and lactate are discussed in full and a more complete review of 
SERS probes for direct bioanalytical measurements is given. Here, we will focus primarily on 
the application of SERS probes for measurement of DNA and proteins in indirect assays for 
biofluid sample analysis in this section. Vo-Dinh pioneered much of the work using SERS for 
detection of organic materials beginning in 1984, when Vo-Dinh et al.(77) reported the use of 
SERS substrates for quantitative detection of organic compounds including benzoic acid. Ten 
years later, in 1994, Vo-Dinh et al.(78) went on to report on the first SERS based DNA gene 
probe. They report on the use of surface-enhanced Raman gene (SERG) probes for the indirect 
detection of specific nucleic acid sequences, using cresyl fast violet labeled oligonucleotide 
sequences designed to target specific complementary sequences, followed by SERS detection 
on silver-coated alumina substrates. In this initial study, the potential for SERS in DNA 
detection with both high sensitivity and specificity was highlighted, and the potential for high 
multiplexing capabilities was alluded to but not demonstrated. Detection of specific DNA 
sequences is a vital tool in molecular biology for application to DNA sequencing, gene 
identification, and diagnostics, often applied to detection of bacterial or viral DNA for disease 
diagnosis.  
 
In 1998, Narayana et al.(79) reported the first use of SERS combined with the polymerase 
chain reaction (PCR) applied to detection of the human immunodeficiency virus gag gene 
sequence. Here, the SERS probe was used as a primer for PCR, and following probe capture, 
the presence of the SERS probe was measured following silver deposition for SERS 
enhancement. In an earlier study in 1997, Graham et al.(25) reported, on the use of surface 
enhanced resonance Raman scattering (SERRS) for detection of DNA at ultralow 
concentration, mitigating the need for PCR, by using resonant Raman probes. SERRS allows 
greater enhancement factors, and consequently lower detection limits, achieved by tuning 
the laser frequency to the maximum absorbance frequency of the dye used in detection. In 
contrast to the work from Vo-Dinh, where the captured probes were detected by application 
to a solid SERS substrate subsequent to capture steps, Graham et al. adsorbed the dye labeled 
DNA probes directly onto the surface of colloidal silver nanoparticles. They applied spermine 
to create a positive layer on the negatively charged DNA backbone, which allowed efficient 
attachment of DNA probes to negatively charged colloidal silver. This highly effective method 
also allowed further enhancement of SERRS signals as excess spermine caused colloidal 
aggregation, further increasing electromagnetic enhancement. By using these additional 
enhancement approaches, the requirement for PCR amplification of target sequences could 
be eliminated.  
 
Graham et al.(80) went on to demonstrate the ability of their SERRS assay to detect two 
different DNA targets in a single assay, giving the first experimental example of multiplexed 
detection of DNA by SERRS. The measurement capabilities of SERS and SERRS for multiple 
targets has since then been widely demonstrated in a number of studies. In 2002, Cao et 
al.(81) reported a microarray chip setup for detection of six different specific DNA or RNA 
sequences, individually immobilized onto a solid substrate, with high sensitivity and 
selectivity. Preparing six different probes by functionalizing gold nanoparticles with six 
different specific dye labeled oligonucleotide sequences, they were able to demonstrate high 
selectivity for detection of the presence of each complementary oligonucleotide sequence 
using a Raman scanning method, however this assay was not carried out on a true multiplexed 
sample in solution. This technique also required a silver enhancement step before Raman 
measurement to allow sufficient SERS enhancement of dye signals. For high-throughput 
applications minimizing additional steps is desirable, but this additional enhancement step 
allowed unoptimized detection limits of 20 fM to be achieved. Faulds et al.(82) addressed 
some important considerations for multiplexed SERRS detection, by demonstrating 
quantitative linear concentration curves for eight different dye labeled oligonucleotides 
adsorbed onto silver colloid. In this study, sufficient signal enhancement was achieved from 
silver colloid, removing the need for additional enhancement steps. As in previous studies by 
Graham et al.(25), the use of spermine, which caused nanoparticle aggregation, also helps to 
further enhance SERRS signal. The ability to determine quantitative information regarding 
oligonucleotide concentration, with detection limits down to 0.5 fM, provided further 
evidence of the benefit of SERS and SERRS as an alternative to fluorescence. Faulds et al.(83) 
went on to demonstrate the ability to quantitatively detect the presence of five specific 
oligonucleotide sequences in a mixture of all species using their dye labeled oligonucleotide 
nanoparticle probes and two different excitation wavelengths (Figure 4). In 2008, Faulds and 
Goodacre et al.(47) improved multiplexing capability further to six oligonucleotides in a 
mixture by employing multivariate analysis, and in 2014 Gracie et al.(46) provided the first 
example of quantification within a multiplex assay for application to detection of bacterial 
meningitis pathogens. Finally, a PCR and SERS based DNA detection approach is now being 
employed clinically to detect fungal disease using the RenDx Fungiplex assay developed by 
Renishaw Diagnostics.(84) 
 
In addition to oligonucleotide detection, SERS and SERRS probes have been widely studied for 
protein detection. Most of these approaches are based on the commonly used immunoassay 
and ELISA assays. SERS probes are being employed in place of fluorescent markers in an 
attempt to increase sensitivity and multiplexing capability, as already discussed in application 
to oligonucleotide detection. Again, it is possible to detect proteins directly, however, it is 
much more common for an indirect approach using a sandwich type immunoassay, where 
signal from a dye labeled nanoparticle is measured, to be employed to achieve the necessary 
sensitivity and specificity. Protein detection methods are incredibly important in 
immunohistochemistry, where tissue sections are stained to investigate expression of various 
proteins. Therefore, protein detection by SERS will be extensively covered in Section 3.2 when 
considering ex vivo tissue bioanalysis by SERS. Rohr et al.(73) were the first to report the use 
of SERS for detection in an immunoassay in 1989. Since then, the advantages of SERS and 
SERRS for increased sensitivity and multiplexing capability in immunoassays has been 
demonstrated. Cui et al.(85) used two methods to perform a SERS based multiplex 
immunoassay capable of detecting two different antigens (mouse IgG and human IgG), one 
method based on the same nanoparticles with different dyes and the other based on different 
nanoparticles with the same dye. Wang et al.(86) reported further multiplexing capability by 
demonstrating ability to use SERS for quantitative detection of four target antigens (mouse 
IgG, human IgG, rabbit IgG and rat IgG). In this study, an alternative binding approach was 
used to covalently attach antibodies to nanoparticles via the reporter dye in order to increase 
specificity of binding. In another study, Wang et al.(87) demonstrated the advantage of SERS 
immunoassays in terms of sensitivity and improved limit of detection. They used a SERS based 
sandwich assay to detect MUC4 in patient sera as a marker of pancreatic cancer, with a ca. 
1000 × lower limit of detection and ca. 10 × lower sample volume requirement than gold 
standard techniques.  
 
The enzyme linked immunosorbent assay (ELISA) is another common method for protein 
detection, which uses an enzyme labeled antibody during detection, converting a non-colored 
substrate into a colored product that can be measured. Dou et al.(88) demonstrated an 
analogous assay using SERS as the detection technique, where the substrate, peroxidase, is 
converted to azoaniline, which has a strong SERRS spectrum. In addition to general protein 
detection, SERS and SERRS have been employed for enzyme detection and measurement of 
specific enzyme activity. Larmour et al.(89) summarized the utility of SERRS for enzyme 
measurements. Moore et al.(90) demonstrated the ability of SERRS for detection of hydrolase 
activity at ultra-low levels, down to that found within single cells.  
 
3.2 Ex vivo tissue  
In 2006 Schlücker et al.(74) ƌĞƉŽƌƚĞĚ ƚŚĞ ĨŝƌƐƚ ƵƐĞ ŽĨ ^Z^ ƉƌŽďĞƐ ĨŽƌ  “ŝŵŵƵŶŽ-Raman 
ŵŝĐƌŽƐƉĞĐƚƌŽƐĐŽƉǇ ? ? dƌĂĚŝƚionally, a trained pathologist analyses stained patient biopsies 
through a microscope and makes an appropriate diagnosis. WhilĞƚŚŝƐŝƐƚŚĞ ‘ŐŽůĚƐƚĂŶĚĂƌĚ ?
technique, is relies on a subjective assessment, which is subject to error. Schlücker et al.(74) 
have set the scene for the use of SERS as an alternative spectroscopic approach for tissue 
diagnostics. SERS is subject to fewer background contribution issues than label free 
spectroscopic imaging techniques, and allows much faster imaging. Instead of relying on 
native biochemical signals, SERS works in a similar way to fluorescence staining for specific 
biomarkers; instead of coupling the specific antibody to a fluorescence marker, it is coupled 
to a SERS probe. The major advantages that SERS probes exhibit over their analogous 
fluorescence probes is increased sensitivity and increased multiplexing capability for the 
detection of multiple markers in a single measurement.   
 
The use of SERS probes as immune markers in tissue diagnostic remains a relatively new area 
of research. However, since it was first demonstrated in 2006, a number of significant studies 
have emerged highlighting the multiplexing capabilities of a SERS approach. Lutz et al.(91) 
reported seminal advances in tissue imaging using SERS, where they employed their 
composite organic-inorganic nanoparticles (COINs)(92) to target two different antibodies 
(cytokeratin-18 (CK-18) and prostate specific antigen(PSA)) in formalin fixed paraffin 
embedded tissue sections (Figure 5). Lutz et al.(91) introduced multivariate data analysis 
methods to allow multiplex spectral signals to be separated and quantified. They used 
spectral fitting based on least-squares regression and reference pure COIN spectra, 
background reference, and freely varying polynomial components to extract contribution of 
individual COIN from multiplex spectra. They were able to demonstrate the ability of their 
developed technique to quantify four different contributions from PSA-antibody-COIN probes 
in a plate-based assay (all specific to PSA antigen but with different Raman reporters  ? acridin 
orange (AOH), basic fuschin (BFU), Nile blue A (NBA) and tetramethyl rhodamine 
isothiocyanate (TMR)). They then went on to demonstrate the ability to distinguish two 
different antigen expressions (CK-18 and PSA) in a tissue section (Figure 5).  Salehi et al.(93) 
more recently demonstrated the sensitivity of immuno-SERS, with the ability to detect single 
nanoparticles. They have also demonstrated multiplexing capability of immune-SERS, 
investigating colocalization of p63 and PSA in non-neoplastic prostate tissue.(94) 
 
Finally, in addition to fixed and sectioned tissue, SERS has also been used for detection of 
specific antigens in excised tissue sections. This could allow excised tissue to be analyzed 
intraoperatively to determine if a tumor has been fully excised by targeting nanoparticles to 
tumor-specific antigens and measuring response in excised tissue to determine if the antigen 
remains at the outer surface. This can guide further excising intraoperatively to ensure 
sufficient removal. Sinha et al.(75) investigated the potential of nanoparticles targeted to the 
EGFR receptor to be used in intraoperative surgery to assess breast cancer tumor margins. 
Here the presence of non-specific binding of nanoparticles was highlighted as a problem in 
this approach, and a dual-probe approach was ĂƉƉůŝĞĚ ?ƋƵĂŶƚŝĨǇŝŶŐ ‘ďŝŶĚŝŶŐƉŽƚĞŶƚŝĂůƐ ?ƚŚĂƚ
take into account these non-specific interactions. Wang et al.(95) highlighted the 
heterogeneous characteristics of tumor xenograft specimens and human breast cancer 
tumors and demonstrated the use of a number of nanoparticle probes for multiplexed 
detection of multiple cancer biomarkers (EGFR and HER2) on an excised tumor quantitatively, 
in order to better guide intraoperative resection.  
 
4. In vivo measurements 
In vivo SERS measurements have been developed using different approaches over recent 
years, including implantable substrates utilized in glucose detection.(96, 97) However, a large 
portion of recent reports make use of SERS probes, plasmonic metal nanostructures 
functionalized with one of a number of Raman reporters, an anti-fouling surface coating (poly-
ethylene glycol or silica, among others) and in the case of targeted SERS probes, a bio-
recognition molecule capable of binding to a biomarker of interest. Non-targeted SERS probes 
have also been utilized which lack a bio-recognition molecule. In a similar fashion to in vitro 
and ex vivo assays, this strategy allows for multiplexed detection, or the detection of multiple 
biomarkers simultaneously through the use of multiple Raman reporters and bio-recognition 
molecules. 
 
Much of the ground-breaking work for the use of SERS probes for in vivo applications was first 
reported in 2008. First, Qian et. al.(98) showed the functionalization of Au nanoparticles with 
Raman dyes, poly-ethylene glycol (PEG) and single-chain variable fragment (ScFv) antibodies 
capable of targeting epidermal growth factor receptors (EGFR), known to be over-expressed 
in specific cancers. Targeted and non-targeted probes were injected into the tail of xenograft 
tumor-bearing mouse models. The targeted probes showed a greater affinity both for the 
tumor mass vs. the liver, and for the tumor mass when compared to their non-targeted 
counterparts. In the same year, Keren and coworkers showed the simultaneous, multiplexed 
detection of two non-target probes injected subcutaneously into a mouse model.(99) This 
strategy was later expanded for the detection of 10 tags at separate injection sites, and five 
tags simultaneously in the liver after intravenous injection.(100) In a promising development, 
the SERS signal intensity observed from multiple tags in the liver was found to track linearly 
with the injected probe concentration. Recent studies with novel nanostructure geometries, 
such as plasmonic Au/Ag hollow shell assemblies(101) and nanostars(102) have followed 
similar experimental strategies.  
 
Building upon these advances, among others in probe development(103, 104), in vivo, 
multiplexed detection of targeted nanoprobes in a mouse model was demonstrated by Maiti 
et al. in 2012.(105) In this study, near-IR SERS reporters were used to label three species of 
bovine serum albumin (BSA) and glutaraldehyde encapsulated probes; two species served as 
positive controls with antibodies targeting the same biomarker (EGFR), and a third as a 
negative control, targeted to human epidermal growth factor 2 (HER2), which is expressed in 
lower levels in the tumor type. After tail-vein injection, probes targeted with anti-EGFR were 
shown to localize selectively in the tumor site via SERS spectroscopy and mapping, while all 
three tags were shown to be present in the liver as in previous non-targeted studies.(99) 
Dinish et al. have taken this further by detecting multiple, different biomarkers in a 
multiplexed measurement.(106) Simultaneous detection of three breast cancer biomarkers ? 
EGFR, CD44, and TGF beta receptor II (TGFEII)  ? was demonstrated by antibody-targeted 
probes after inter-tumoral injection. Targeted probes were shown to remain in the model 
mass up to 48 hours before clearing after 72 hours, whereas non-targeted probes with the 
same reporters were largely cleared within 6 hours, and completely absent after 24 hours. 
This work is featured in Figure 6. Notably, non-specific binding by an isotype antibody was not 
investigated in this study.  
 
Wang and coworkers have shown an important step toward biomarker quantification and 
monitoring in vivo with their work on ratiometric, multiplexed detection via SERS probes.(49) 
Topical application of three antibody functionalized probe species ? anti-EGFR, anti-HER2, 
and an isotype control ? was performed on two tumor types with varied expression of EGFR 
and HER2. The first tumor type, A431, is known to overexpress EGFR with modest HER2, 
whereas type two, SkBr3, overexpresses HER2, but with ordinary EGFR. After the topical 
application of probes, the tumors were implanted and SERS measurements taken. The Raman 
data was treated with direct classical least squares (DCLS) processing, allowing for the 
determination of useful probe, and thus biomarker, ratios ? anti-EGFR/isotype, anti-
HER2/isotype, and anti-EGFR/anti-HER2 ? in the two tumor types and control tissue with very 
positive results. The inclusion of an isotype probe makes for robust measurement by 
providing a control for non-specific probe binding.  
 
Apart from the cancer field, there has also been interest in the use of SERS probes for the 
diagnosis of other diseased states in vivo. McQueenie et al. demonstrated one such example 
in 2012.(107) Here, intracellular adhesion molecule 1 (ICAM-1) was targeted, as its expression 
in the vasculature is an early indication of inflammation and atherosclerosis. After inducing 
inflammation with an injection of lipopolysaccharide (LPS), anti-ICAM functionalized 
nanoparticles were detected via SERS measurements in the ear pinnae of murine models, 
with favorable results vs. an isotype probe control.  
 
As mentioned in the introduction, the Raman instrument used in a SERS probe experiment is 
of critical importance, particularly in vivo, where traditional spectrometers or microscopes 
may not be optimal. Many advances in instrumentation have been driven by the necessity for 
purpose-built spectrometers for in vivo detection of SERS probes. Notable examples of the 
synergistic benefits of non-targeted SERS probes coupled with cutting-edge spectrometers 
include an endoscopic probe for multiplexed detection(36), a handheld probe for guidance in 
brain tumor resection (34), and a circumferentially scanning probe for the interrogation of 
luminal probe-treated surfaces(37). Similar to their previous targeted, ratiometric work, 
Wang et al. recently showed impressive multiple biomarker detection in esophageal cancer 
models using a probe-scanning system.(108) Further, two separate configurations for imaging 
large areas, one utilizing a line-scanning configuration(39) and another with widefield 
excitation and a tunable filter for multiplexed detection(40) have also been demonstrated. 
SESORS (surface enhanced, spatially- offset Raman spectroscopy) combines the sub-surface 
sampling capabilities of spatially-offset Raman spectroscopy (SORS) with the sensitivity of 
SERS. This technique was first demonstrated by Stone et. al. with probes buried 25 mm into 
mammalian tissue(42), with later work showing probe detection up to 50 mm(43). Sharma et. 
al. have recently shown probe detection through bone(44), expanding the potential for 
SESORS in future clinical applications. Separately, SESORS has also been demonstrated with 
implanted SERS substrates, in lieu of SERS probes, for glucose detection(97, 109) in vivo. 
 
Finally, many efforts have been made to produce probes detectable via multiple imaging 
techniques, so-called multimodal imaging SERS probes, for use in vivo. By creating probes that 
can be visualized via complementary contrast mechanisms, one might attain valuable 
information absent when a single mechanism is used, leading to better detection or perhaps 
more accurate tumor resection. In addition to the properties of traditional SERS probes, these 
probes are comprised of varied materials, allowing them to be detected via fluorescence 
(FL)(110-112), photothermal (PT)(113-117), magnetic resonance (MRI)(118-120), Fourier-
Transform Infrared (FTIR)(121), photoacoustic (PA)(118, 122), or computed X-ray (CT)(116, 
117, 119) imaging. An in-depth investigation into multimodal probes is outside of the scope 
of this review, but has been discussed previously by others.(123-125) 
 
5. Conclusion 
In this review we have provided an overview of some of the seminal examples of SERS probes 
for use in bioanalytical measurements. This is a field that has vastly expanded since the 
discovery of SERS in 1974, and its subsequent exploitation for analysis of biological samples 
is the result of the significant advantages it can provide for rapid, sensitive and multiplexed 
measurements. As with any analytical technique, there are fundamental considerations that 
have to be made when developing a SERS probe measurement, particularly if the ultimate 
goal is to translate these techniques into clinical applications. Major considerations required 
when developing a SERS probe are biological sample preparation, SERS probe selection, 
instrumental considerations and data interpretation.  
 
We have demonstrated the use of SERS probes as bioanalytical tools, with particular focus on 
diagnostics, in application to in vitro cell culture models, ex vivo biofluid and tissue samples 
and in vivo detection. These studies highlight the unique and beneficial properties of SERS 
probes for highly sensitive, and often multiplexed, detection of biomolecules of interest. As a 
result of the intense and sharp characteristics of SERS signals, SERS probes are already pushing 
detection limits for specific biomolecules, such as DNA and proteins. In the future it is likely 
that these limits will be pushed further, providing increased momentum for translation of 
SERS-based assays into the clinic. This is particularly true for detection of biomarkers in 
biofluid samples, where one assay for fungal detection is already commercially available(84). 
Multiplexing capability is another prominent advantage of SERS over other techniques, and it 
is likely that multiplexing capabilities will be expanded in coming years from the currently 
reported 6-plex assay from Faulds et al.(47). As well as paving the way for in vivo studies, in 
vitro studies have an important place in their own right, and one particular clinical application 
that could be pursued would be a high-throughput SERS platform for drug screening. Finally, 
perhaps the ultimate goal is to be able to perform robust and accurate in vivo diagnostics, 
and future work for in vivo application will push current work in animal models into humans. 
While there are clear toxicity considerations, SERS probes show promise for clinical 
application for early disease detection whilst being minimally invasive. Therefore, SERS 
probes provide vast scope for addressing some of the key, present-day problems in 
bioanalysis and clinical assays. Studies featured in this review have demonstrated the strong 
research base that has established the applicability of the SERS approach in addressing these 
problems.  
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 Figure 1 A summary of the key considerations to be made when performing bioanalytical SERS measurements. 
 Figure 2 Schematic of the general design of a SERS probe showing the components used: SERS substrate, Raman dye (optional) and biomolecule (optional), 
and examples of each. Some common SERS probe designs are given showing different attachment mechanisms. (A) Attachment of a specific antibody can be 
achieved via covalent attachment of a thiol modified polyethylene glycol (PEG) linker. A Raman dye is also covalently attached to the nanoparticle surface via 
a thiol linker, and gives a characteristic SERS response (yellow spectrum). (B) Attachment of a specific oligonucleotide sequence via electrostatic interaction 
between negatively charged nanoparticle surface and positively charged modified base sequence. A Raman dye is also covalently attached to the nanoparticle 
surface via a thiol linker, and gives a characteristic SERS response (pink spectrum). (C) Attachment of a specific Raman dye labelled and thiol modified 
oligonucleotide sequence via covalent attachment. The Raman dye label gives a characteristic SERS response (blue spectrum).   
 Figure 3 (1) Multi-targeting SERS imaging of a HeLa cell treated with both label free membrane- and nucleus-targeting gold nanoparticles. (A) SERS image and 
(B) brightfield image of the investigated HeLa cell. (C) SERS spectra obtained from different positions within the cell such as membrane (blue), cell nucleus 
(red) and the surrounding environment (black) show significant differences in terms of their intensity and peak positiŽŶƐ ?ƐĐĂůĞďĂƌ൙ ?ʅŵ ? ? ? ? ?DƵůƚŝ-targeting 
SERS imaging of a HeLa cell treated with CVa-coated, CV-coated, and MBA- coated gold nanoparticles. (A) Overlap of SERS images of CVa-coated gold 
nanoparticles(red), CV-coated gold nanoparticles (green), and MBA- coated gold nanoaprticles (blue). (B) The bright-field image of the investigated HeLa cell. 
(C) SERS spectra obtained from different positions in the cell (marked in panel B by arrows). The Raman intensities at 595, 1078, and 1175 cmAL1 revealed the 
relative amount of CVa-coated, MBA-coated and CV-ĐŽĂƚĞĚƵEWƐĂƚƚŚĞĐŽƌƌĞƐƉŽŶĚŝŶŐƉŽƐŝƚŝŽŶƐ ?ƌĞƐƉĞĐƚŝǀĞůǇ ?ƐĐĂůĞďĂƌ൙ ?ʅŵ ? ?Adapted from Chen et 
al.(69). Copyright 2016 by Nature Publishing Group.   
  
 
Figure 4 (A) SERRS spectra of silver nanoparticles taken using a 514.5 nm laser (left) and 632.8 nm 
laser (right) for nanoparticles functionalized with different oligonucleotide sequences each modified 
with a different Raman dye molecule: rhodamine 6G (R6G) labeled human papillomavirus (HPV) probe 
(red); FAM labelled universal reverse primer (green);  ROX labelled VT2 E. Coli 157 gene probe (yellow); 
Cy5.5 labelled universal reverse primer (purple); and BODIPY TR-X labelled universal reverse primer 
(cyan). R6G and FAM had the highest SERRS signals at 514.5 nm, while ROX, Cy5.5 and Bodipy had the 
highest SERRS signals at 632.8 nm. (B) SERRS spectra of a mixture of all five labelled nanoparticle 
probes at a concentration of 1.82 × 10AL9 M taken using a 514.5 nm laser (left) and 632.8 nm laser 
(right), indicating SERRS signals from each labelled nanoparticle in each case. (C) Calibration of each 
labelled nanoparticle in a mixture of all nanoparticle probes using 514.5 nm excitation for R6G and 
FAM labelled probes (left) and 632.8 nm excitation for ROX, Cy5.5 and Bodipy probes (right). Adapted 
from Faulds et al.(83). Copyright © 2007 by John Wiley & Sons, Inc. Reprinted by permission of John 
Wiley & Sons, Inc.   
  
 Figure 5 (A) Brightfield image of section of prostate tissue, which was targeted with antibody labelled SERS probes and raster scanned using a 532 nm laser 
such that a SERS spectrum was taken from each black spot in the 50 × 50 area with 1 µm spacing between points. Brightfield image is labelled to show tissue 
features  ? epithelia (E) of two different prostate lands, stromal tissue between the glands (S) and gland lumen (L). Scale bar = 10 µm (B) A SERS probe for 
detection of cytokeratin-18 (CK-18) by conjugation with anti-CK18 antibody and the Raman dye basic fuschin (BFU) (BFU-CK18, red) was used to locate CK18 
antigen on the tissue section (top left). A SERS probe for detection of prostate specific antigen (PSA) by conjugation with anti-PSA antibody and the Raman 
dye acridin orange (AOH) (AOH-PSA, green) was used to locate PSA antigen on the tissue section (top right). A DNA fluorescent dye (YOYO) was used to detect 
nuclear regions (bottom left). Colocalization of signals is shown in the bottom right image. Scale bars = 10 µm. (C) Deconvolution of spectrum from a single 
point in map. The measured spectrum (grey) and best-fit spectrum (black) are shown in the upper spectrum. Extracted spectra for BFU-CK18 (re), AOH-PSA 
(green) and YOYO (blue) are given below. Adapted with permission from Lutz et al.(91). Copyright 2008 American Chemical Society.  
  
 Figure 6 Demonstration of targeted, in vivo, multiplexed detection in a xenograft tumor model. Panel (A) shows an image of a tumor bearing 
mouse used in the experiments. Panel (B) features SERS spectra from non-targeted nanotags at the tumor site as a function of time after 
exposure. Peaks at 1120, 1175 and 1650 cmAL1 correspond to tags with the dyes Cy5, MGITC, and Rh6G, and the disappearance of these peaks 
over time suggests clearance of tags from the site after 6 hours. Panel (C) shows SERs spectra from antibody functionalized SERS nanotags as a 
function of time. The presence of peaks associated with Cy5/TGFbRII, MGITC/CD44, and Rh6G/EGFR targeted tags after 24, and up to 48 hours, 
after exposure demonstrates the retention effect of targeted nanotags when they are designed to bind to specific tumor biomarkers. Reproduced 
from Dinish et.al.(106). Copyright 2014 by Nature Publishing Group. 
